Treatment incidence of and medical utilization for hospitalized subjects with pathologic fractures in Taiwan-Survey of the 2008 National Health Insurance data

BackgroundAlmost all studies of pathologic fractures have been conducted based on patients with tumours and hospital-based data; however, in the present study, a nationwide epidemiological survey of pathologic fractures in Taiwan was performed and the medical utilization was calculated.MethodsAll claimants of Taiwan's National Health Insurance (NHI) Program in 2008 were included in the target population of this descriptive cross-sectional study. The registration and inpatient expenditure claims data by admission of all hospitalized subjects of the target population were examined and the concomitant International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes were evaluated and classified into seven major categories of fracture.ResultsA total of 5,244 incident cases of pathologic fracture were identified from the 2008 hospitalized patient claims data. The incidence of pathologic fracture of the humerus, distal radius/ulna, vertebrae, femoral neck, other part of the femur, and tibia/fibula was 0.67, 0.08, 10.58, 1.11, 0.56, and 0.11 per 100,000 people, respectively, and patients with those fractures were hospitalized for 43.9 ± 42.9, 31.1 ± 32.9, 29. 4 ± 34.4, 43.3 ± 41.2, 42.4 ± 38.1, and 42.0 ± 32.8 days, respectively, incurring an average medical cost of US$11,049 ± 12,730, US$9,181 ± 12,115, US$6,250 ± 8,021, US$9,619 ± 8,906, US$10,646 ± 11,024, and US$9,403 ± 9,882, respectively. The percentage of patients undergoing bone surgery for pathologic fracture of the humerus, radius/ulna, vertebrae, femoral neck, other part of the femur, and tibia/fibula was 31.2%, 44.4%, 11.3%, 46.5%, 48.4%, and 52.5% respectively.ConclusionsComparing Taiwan to other countries, this study observed for Taiwan higher medical utilization and less-aggressive surgical intervention for patients hospitalized with pathologic fractures.

[1]  Z. Lidar,et al.  Surgical management of metastatic bone disease. , 2009, The Journal of bone and joint surgery. American volume.

[2]  G. Roodman Mechanisms of bone metastasis. , 2004, Discovery medicine.

[3]  M. Yaszemski,et al.  Metastatic bone disease: diagnosis, evaluation, and treatment. , 2009, The Journal of bone and joint surgery. American volume.

[4]  M. Heim,et al.  Nonoperative treatment of intracapsular fractures of the proximal femur. , 2002, Clinical orthopaedics and related research.

[5]  K. Tomita,et al.  Surgical Strategy for Spinal Metastases , 2001, Spine.

[6]  K. Schulman,et al.  Economic burden of metastatic bone disease in the U.S. , 2007, Cancer.

[7]  M. A. Smith,et al.  The surgical treatment of metastatic disease of the spine. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  S. Skjeldal,et al.  The Scandinavian Sarcoma Group skeletal metastasis registerSurvival after surgery for bone metastases in the pelvis and extremities , 2004, Acta orthopaedica Scandinavica. Supplementum.

[9]  R. Lenzi,et al.  Diagnostic strategies for unknown primary cancer , 2004, Cancer.

[10]  F. Sim,et al.  Surgical Treatment of Metastatic Disease of the Femur , 2000, The Journal of the American Academy of Orthopaedic Surgeons.

[11]  C. U. Uyl‐de Groot,et al.  Costs of prostate cancer, metastatic to the bone, in the Netherlands. , 2003, European urology.

[12]  E. Mindell,et al.  Treatment of pathological fractures of long bones excluding those due to breast cancer. , 1976, The Journal of bone and joint surgery. American volume.

[13]  M. Dominkus,et al.  Metastatic bone disease: A 36‐Year single centre trend‐analysis of patients admitted to a tertiary orthopaedic surgical department , 2007, Journal of surgical oncology.

[14]  S. Ponzer,et al.  Fractures of the shaft of the humerus. An epidemiological study of 401 fractures. , 2006, The Journal of bone and joint surgery. British volume.